login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
NOVARTIS AG-SPONSORED ADR (NVS) Stock News
USA
- NYSE:NVS -
US66987V1098
-
ADR
122.975
USD
+0.68 (+0.56%)
Last: 9/19/2025, 2:49:00 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
NVS Latest News, Press Relases and Analysis
All
Press Releases
4 days ago - By: Chartmill
Novartis AG-Sponsored ADR (NYSE:NVS) Presents a Compelling Case for Value Investors
10 days ago - By: Chartmill
- Mentions:
FCEL
MSFT
AAPL
DELL
...
Wall Street Cheers Nebius-Microsoft Megadeal While Apple Misses the Mark
2 days ago - By: Zacks Investment Research
- Mentions:
ABUS
Is Novartis (NVS) Stock Outpacing Its Medical Peers This Year?
2 days ago - By: Zacks Investment Research
- Mentions:
INCY
ANIP
CRMD
INCY Announces New Late-Stage Data on Skin Disease Drug
4 days ago - By: Stocktwits
- Mentions:
GLUE
Monte Rosa Therapeutics Stock Scores Biggest Gain In Nearly A Year On $5.7B Novartis Deal For Immune-Mediated Diseases
4 days ago - By: Benzinga
- Mentions:
GLUE
Monte Rosa, Novartis Use AI-Powered Engine To Advance Immune Disease Treatments
7 days ago - By: Benzinga
- Mentions:
AMAT
ARRY
STZ
RH
This Applied Materials Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday
7 days ago - By: Bloomberg
How AI Company Isomorphic Labs Is Working to Solve All Disease | Bloomberg Tech: Europe 9/12/2025
8 days ago - By: Stocktwits
- Mentions:
GOOG
LLY
Google DeepMind Chief Eyes Radical AI-Powered Shift In Drug Discovery Speed — Eli Lilly, Novartis Are Already Onboard
8 days ago - By: Stocktwits
- Mentions:
RNA
Why Is Avidity Biosciences Stock Down 20% Pre-market Today?
9 days ago - By: Zacks Investment Research
- Mentions:
PFE
JNJ
LLY
5 Large Drug Stocks to Watch Despite Industry & Macro Headwinds
9 days ago - By: Zacks Investment Research
- Mentions:
NVO
TRML
NVS to Acquire TRML, Add Phase III Cardiovascular Drug to Pipeline
10 days ago - By: Investor's Business Daily
- Mentions:
TRML
NVO
Novartis Snaps Up Cardio-Focused Tourmaline Bio For $1.4 Billion
10 days ago - By: Investor's Business Daily
- Mentions:
TRML
NVO
Why Novartis' $1.4 Billion Takeover Of Tourmaline Bio Just 'Makes Sense'
10 days ago - By: Invezz
Tourmaline Bio surges after Novartis $1.4 billion acquisition; analysts see strong fit
10 days ago - By: Stocktwits
- Mentions:
TRML
Tourmaline Bio Stock Just Rocketed 58% Pre-Market – Here’s What Happened
11 days ago - By: Chartmill
Novartis AG (NYSE:NVS) Offers a Compelling Mix of Dividend Yield, Profitability, and Financial Health
Please enable JavaScript to continue using this application.